mpitram
mpitram 3Speak Podcast
Listen and watch the latest videos from mpitram. Hosted by 3Speak.tv. The free speech video platform on the HIVE blockchain.
No dejes de visitar la web del podcast y apoyar a su creador: 3speak.tv
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Instálala gratis
Android casi 10 M de descargas · valoración de 4,7+
iOS muy pronto
Episodios
SHOCKING💥EVIDENCE THAT NICOTINE IS A POWERFUL DETERRENT FOR COVID, ALZHEIMER’S, PARKINSON’S, AUTISM Video 16.08.2025 11:41
https://3speak.tv/watch?v=mpitram/trrpwike 💥SHOCKING💥EVIDENCE THAT NICOTINE IS A POWERFUL DETERRENT FOR C0¥ID, ALZHEIMER’S, PARKINSON’S, AUTISM, ETC.: DR. BRYAN ARDIS - AND THEY'RE BANNING IT LIKE IVERMECTIN...
They like them Young. Wikipedia KILLS ALL Epstein quotes. Video 09.08.2025 1:40
https://3speak.tv/watch?v=mpitram/wusihsyb Wikipedia KILLS ALL Epstein quotes. Same day DoJ moves to meet Ghislaine — footage from Lord Bebo Who controls Wikipedia?
The white fibrous clots found in both the living and dead recipients of the mRNA vaccines Video 06.08.2025 4:31
https://3speak.tv/watch?v=mpitram/opemiwas The white fibrous clots found in both the living and dead recipients of the mRNA vaccines, are being ignored by the mainstream narrative, but the scientific research tells us what they are, and what’s causing them.
Covid convinces people to accept total biomedical surveillance. Video 05.08.2025 0:21
https://3speak.tv/watch?v=mpitram/uhhpbgbt Covid convinces people to accept total biomedical surveillance.
mRNA Vaccines are Gene Therapy. Video 04.08.2025 0:41
https://3speak.tv/watch?v=mpitram/yuvxwqqx mRNA Vaccines are Gene Therapy.
Podcasts similares
Escucha el podcast mpitram 3Speak Podcast en Replaio
Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos
